Evidence map›Paper›PMID 32724301›Full record

ReviewTheScientificWorldJournal2020

Opeyemi I Ayanda, Tolulope Ajayi, Femi P Asuwaju

Abstract readReview
In one paragraph

Review in TheScientificWorldJournal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. The complete mitochondrial genome ofFrontiers in plant science · 2024
    Article
  12. Frontiers in cellular and infection microbiology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Opeyemi I AyandaDepartment of Biological Sciences, Covenant University, Ota, Ogun State, Nigeria.ORCID https://orcid.org/0000-0001-6881-0999
Tolulope AjayiDepartment of Biological Sciences, Covenant University, Ota, Ogun State, Nigeria.
Femi P AsuwajuDepartment of Aquaculture and Biotechnology, National Institute for Freshwater Fisheries Research, New Bussa, Niger State, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Water hyacinths pose serious challenges to humanity and the environment. Considering the enormity of the menace associated with the growth and spread of the plant and the difficulty in achieving a single, generally acceptable control method, it is becoming increasingly imperative to explore the potentials of the plant. New water hyacinth-related articles are regularly being published. Recently published articles about the plant were accessed, and the information in these articles is presented in the context of the pros and cons of the plant. Some of the benefits that can be derived from the plant include biogas and biofuel production, medicinal functions, vermicomposting, compost production, and bioremediation. However, clogging of waterways, obstruction of water transportation, and fishing activities; breeding grounds for pests and diseases; and reduction of water quality, loss of biodiversity, and economic downturn in areas invaded by the plant are problems associated with it. The peculiarity in the invasiveness of each situation should determine whether or not the growth of the plant is a problem, especially if the opportunity to harness the potentials of the plant exists. There are three major methods for controlling the plants when control becomes inevitable: mechanical, chemical, and biological. To achieve the best control, integrating two or more control methods is advised.

Indexed as

Animal FeedBiofuelsCompostingAnimalsBiodegradation, EnvironmentalBiodiversityBiological Control AgentsDisease VectorsEichhorniaFisheriesHumansPlants, MedicinalPlant WeedsSocioeconomic FactorsWater QualityBiofuelsBiological Control Agents

Identifiers

PMID32724301
PMCPMC7364201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.